Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.
Sustained activation of JAK/STAT3 signaling pathway is classically described in Multiple Myeloma (MM). One explanation could be the silencing of the JAK/STAT suppressor genes, through the hypermethylation of SHP-1 and SOCS-1, previously demonstrated in MM cell lines or in whole bone marrow aspirates...
Main Authors: | Asma Beldi-Ferchiou, Nour Skouri, Cyrine Ben Ali, Ines Safra, Abderrahman Abdelkefi, Saloua Ladeb, Karima Mrad, Tarek Ben Othman, Mélika Ben Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5378363?pdf=render |
Similar Items
-
Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication
by: Liu J, et al.
Published: (2017-03-01) -
Shp1 in Solid Cancers and Their Therapy
by: Alessia Varone, et al.
Published: (2020-06-01) -
Lack of expression phosphotyrosinephosphatase SHP-1 in K562 cells results from hypermethylation of the SHP-1 promoter
by: Lin-Ya Tang, et al.
Published: (2002) -
Interleukin-3 (IL-3) signal transduction in haemopoietic cells : the role of SHP-1, SHP-2, and SHC
by: Bone, Heather Karyn
Published: (1999) -
Shp2 knockdown and Noonan/LEOPARD mutant Shp2-induced gastrulation defects.
by: Chris Jopling, et al.
Published: (2007-12-01)